Liuqi Shi

600 total citations
17 papers, 488 citations indexed

About

Liuqi Shi is a scholar working on Molecular Biology, Ophthalmology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Liuqi Shi has authored 17 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Ophthalmology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Liuqi Shi's work include Natural Compounds in Disease Treatment (4 papers), Corneal Surgery and Treatments (3 papers) and Ocular Surface and Contact Lens (3 papers). Liuqi Shi is often cited by papers focused on Natural Compounds in Disease Treatment (4 papers), Corneal Surgery and Treatments (3 papers) and Ocular Surface and Contact Lens (3 papers). Liuqi Shi collaborates with scholars based in China and United States. Liuqi Shi's co-authors include Jingguo Li, Zhanrong Li, Lin Jin, Liujun Wang, Lemei An, Yong Wang, Xintao Shuai, Dandan Chu, Ruixing Liu and Zhihua Guo and has published in prestigious journals such as Nano Letters, Carbohydrate Polymers and Investigative Ophthalmology & Visual Science.

In The Last Decade

Liuqi Shi

16 papers receiving 476 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Liuqi Shi China 10 162 126 89 83 76 17 488
Kexin Shi China 10 160 1.0× 144 1.1× 11 0.1× 103 1.2× 75 1.0× 24 491
Yuqin Shen China 10 169 1.0× 177 1.4× 38 0.4× 75 0.9× 154 2.0× 38 764
Sankalp Gharat India 10 129 0.8× 199 1.6× 6 0.1× 187 2.3× 66 0.9× 25 615
Jiajie Xu China 16 154 1.0× 201 1.6× 9 0.1× 102 1.2× 100 1.3× 49 782
Ruowei Sun China 7 241 1.5× 257 2.0× 8 0.1× 136 1.6× 36 0.5× 14 610
Gyan Prakash Mishra United States 12 87 0.5× 169 1.3× 10 0.1× 179 2.2× 15 0.2× 21 558
Dipali Patel United States 14 335 2.1× 209 1.7× 23 0.3× 40 0.5× 26 0.3× 16 629
Shuyi Xiao China 8 115 0.7× 143 1.1× 15 0.2× 73 0.9× 37 0.5× 14 484
Chun Fan China 14 110 0.7× 321 2.5× 8 0.1× 46 0.6× 80 1.1× 31 721
Xianyan Qin China 12 89 0.5× 118 0.9× 16 0.2× 106 1.3× 26 0.3× 18 429

Countries citing papers authored by Liuqi Shi

Since Specialization
Citations

This map shows the geographic impact of Liuqi Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liuqi Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liuqi Shi more than expected).

Fields of papers citing papers by Liuqi Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Liuqi Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liuqi Shi. The network helps show where Liuqi Shi may publish in the future.

Co-authorship network of co-authors of Liuqi Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Liuqi Shi. A scholar is included among the top collaborators of Liuqi Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liuqi Shi. Liuqi Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Zhang, Nan, et al.. (2025). Synthesis and Characterization of In Situ Chitosan/Cyclodextrin/Catechol Gel for Rapamycin Delivery. Macromolecular Bioscience. 25(6). e2400596–e2400596.
2.
Huang, Yisheng, Liuqi Shi, Zhiyuan Zhu, et al.. (2025). Hydrophilic–Hydrophobic Sequence Regulation in Alternating Polysulfoniums Enables “Wake-and-Kill” Eradication of Antibiotic-Tolerant Persisters and Their Biofilms. ACS Macro Letters. 14(7). 878–887. 2 indexed citations
4.
Chen, Huiying, Liuqi Shi, Nan Zhang, et al.. (2024). Biophilic Positive Carbon Dot Exerts Antifungal Activity and Augments Corneal Permeation for Fungal Keratitis. Nano Letters. 24(13). 4044–4053. 33 indexed citations
5.
Li, Zhanrong, Zhihua Guo, Dandan Chu, et al.. (2023). Celastrol-based nanoporous membranes prevent subconjunctival fibrosis by activating autophagy. Materials Today Advances. 18. 100356–100356. 10 indexed citations
6.
Liu, Ruixing, et al.. (2023). Antibiotic Delivery System for Treating Bacteria-Induced Anterior Blepharitis. ACS Infectious Diseases. 9(10). 2005–2015. 4 indexed citations
8.
Liu, Ruixing, Jingguo Li, Zhihua Guo, et al.. (2023). Celastrol Alleviates Corneal Stromal Fibrosis by Inhibiting TGF-β1/Smad2/3-YAP/TAZ Signaling After Descemet Stripping Endothelial Keratoplasty. Investigative Ophthalmology & Visual Science. 64(3). 9–9. 9 indexed citations
9.
Zhang, Ying, Ruixing Liu, Chengcheng Li, et al.. (2022). Celastrol-Based Nanomedicine Hydrogels Eliminate Posterior Capsule Opacification. Nanomedicine. 17(20). 1449–1461. 9 indexed citations
10.
Shi, Liuqi, Zhanrong Li, Zhen Liang, et al.. (2021). A dual-functional chitosan derivative platform for fungal keratitis. Carbohydrate Polymers. 275. 118762–118762. 42 indexed citations
11.
Li, Bohua, Liuqi Shi, Ruixing Liu, et al.. (2021). A lingering mouthwash with sustained antibiotic release and biofilm eradication for periodontitis. Journal of Materials Chemistry B. 9(41). 8694–8707. 10 indexed citations
12.
Li, Zhanrong, Xingcai Zhang, Jiang Ouyang, et al.. (2021). Ca2+-supplying black phosphorus-based scaffolds fabricated with microfluidic technology for osteogenesis. Bioactive Materials. 6(11). 4053–4064. 106 indexed citations
13.
Shi, Liuqi, et al.. (2021). Co-Delivery of Paclitaxel and siRNA with pH-Responsive Polymeric Micelles for Synergistic Cancer Therapy. Journal of Biomedical Nanotechnology. 17(2). 322–329. 10 indexed citations
14.
An, Lemei, Zhanrong Li, Liuqi Shi, et al.. (2020). Inflammation-Targeted Celastrol Nanodrug Attenuates Collagen-Induced Arthritis through NF-κB and Notch1 Pathways. Nano Letters. 20(10). 7728–7736. 157 indexed citations
15.
Yang, Fan, Zhihua Guo, Liuqi Shi, et al.. (2020). Antiangiogenic and Antitumor Therapy for Retinoblastoma with Hypoxia-Inducible Factor-1α siRNA and Celastrol Co-Delivery Nanomicelles. Journal of Biomedical Nanotechnology. 16(10). 1471–1481. 17 indexed citations
16.
Guo, Zhihua, Liuqi Shi, Fan Yang, et al.. (2020). Reduction-sensitive nanomicelles: Delivery celastrol for retinoblastoma cells effective apoptosis. Chinese Chemical Letters. 32(3). 1046–1050. 47 indexed citations
17.
Li, Zhanrong, Dandan Chu, Liuqi Shi, et al.. (2019). Biocompatible and Biodegradable 3D Double-Network Fibrous Scaffold for Excellent Cell Growth. Journal of Biomedical Nanotechnology. 15(11). 2209–2215. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026